Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE  
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel,  BELGIË  
 
Tel: +32 229- 91111. Fax: +32 229 -64301. E -mail: COMP -MERGER -REGISTRY@ec.europa.eu.  
  EUROPEAN COMMISSION  
Brussels, 16.6.2021 
C(2021)  4513 final  
PUBLIC VERSION 
Igenomix, S.L.U.  
Calle Narcís Monturiol Estarriol 11  
Parcels B, Edificio Europark,  
Parque Tecnológico de Paterna  
46980 Paterna 
Spain  
 Universal Clinics, S.L.  
Calle Jose Silva 9B   
Madrid  
Spain  
Subject : Case M.10202 – EQT / INVESTINDUSTRIAL / JV 
Commission decision pursuant to Article 6(1)(b) of Council Regulation 
(EC) No  139/20041 and Article 57 of the Agreement on the European 
Economic Area2  
Dear Sir or Madam,  
1. On 21 May 2021, the European Commission received notification of a proposed 
concentration pursuant to Article 4 of the Merger  Regulation by which the 
undertaking  Igenomix, S.L.U. (‘Igenomix’, Spain), solely controlled by EQT AB 
(‘EQT’, Sweden) , and Universal Clinics, S.L . (‘Universal Clinics’, Spain), solely 
controlled by Investindustrial S.A. (‘Investindustrial’, Luxembourg) , acquire within 
the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control over  a 
newly created joint venture (the ‘JV’ ) by way of purchase of shares .3 
2. The business activities of the undertakings concerned are:  
− for EQT:  management of investment funds. Portfolio companies controlled by 
EQT include notably Igenomix, a company dedicated to the business of 
genetic and molecula r diagnostics, as well as clinical and complementary 
                                                 
1 OJ L 24, 29.1.2004, p. 1 ( the ‘Merger Regulation ’). With effect from 1 December 2009,  the Treaty on 
the Functioning of the European Union ( ‘TFEU ’) has introduced certain changes, such as the 
replacement of ‘ Community ’ by ‘Union ’ and ‘common market ’ by ‘internal market ’. The terminology 
of the TFEU will be used throughout this decision.  
2  OJ L 1, 3.1.1994, p.  3 (the ‘EEA Agreement ’). 
3  Publication in the Official Journal of the European Union No C 205, 31.05.2021 , p. 9. 

2 analyses, specialized in the reproductive sector and in vitro fertilisation related 
testing , 
− for Investindustrial: management of investment funds. Portfolio companies controlled by Investindustrial inclu de notably Universal Clinics, a company 
active in reproduction medicine through the ownership, operation and development of health clinics in Spain, Italy, Czech Republic and Sweden, 
− for the JV: development and commercialisation of a non- invasive embryo 
culture medical device to be used by in vitro fertilization laboratories . 
3. After examination of the notification, the European Commission has concluded that 
the notified operation falls within the scope of the Merger  Regulation and of 
paragraph 5 (a) of the Co mmission Notice on a simplified procedure for treatment of 
certain concentrations under Council Regulation (EC) No  139/2004.
4 
4. For the reasons set out in the Notice on a simplified procedure, the European Commission has decided not to oppose the notified operation and to declare it compatible with the internal market and with the EEA Agreement. This decision is 
adopted in application of Article 6(1)(b) of the Merger  Regulation and Article 57 of 
the EEA Agre ement . 
For the Commission  
  (Signed)  
Olivier GUERSENT  
Director -General  
 
                                                 
4  OJ C 366, 14.12.2013, p. 5.